These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2005641)
1. Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. Geleziunas R; McQuillan A; Malapetsa A; Hutchinson M; Kopriva D; Wainberg MA; Hiscott J; Bramson J; Panasci L J Natl Cancer Inst; 1991 Apr; 83(8):557-64. PubMed ID: 2005641 [TBL] [Abstract][Full Text] [Related]
2. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615 [TBL] [Abstract][Full Text] [Related]
3. DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance. Bramson J; McQuillan A; Panasci LC Cancer Lett; 1995 Apr; 90(2):139-48. PubMed ID: 7736449 [TBL] [Abstract][Full Text] [Related]
4. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. Muller C; Christodoulopoulos G; Salles B; Panasci L Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757 [TBL] [Abstract][Full Text] [Related]
5. Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Torres-Garcia SJ; Cousineau L; Caplan S; Panasci L Biochem Pharmacol; 1989 Sep; 38(18):3122-3. PubMed ID: 2783167 [No Abstract] [Full Text] [Related]
6. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related]
7. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line. Pu QQ; Bezwoda WR Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328 [TBL] [Abstract][Full Text] [Related]
8. Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases. Mattes WB; Lee CS; Laval J; O'Connor TR Carcinogenesis; 1996 Apr; 17(4):643-8. PubMed ID: 8625472 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. Moufarij MA; Sampath D; Keating MJ; Plunkett W Blood; 2006 Dec; 108(13):4187-93. PubMed ID: 16954499 [TBL] [Abstract][Full Text] [Related]
10. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Yamauchi T; Nowak BJ; Keating MJ; Plunkett W Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880 [TBL] [Abstract][Full Text] [Related]
11. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. Panasci L; Henderson D; Torres-Garcia SJ; Skalski V; Caplan S; Hutchinson M Cancer Res; 1988 Apr; 48(7):1972-6. PubMed ID: 3349471 [TBL] [Abstract][Full Text] [Related]
12. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Müller MR; Buschfort C; Thomale J; Lensing C; Rajewsky MF; Seeber S Clin Cancer Res; 1997 Nov; 3(11):2055-61. PubMed ID: 9815597 [TBL] [Abstract][Full Text] [Related]
13. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer. Codegoni AM; Broggini M; Pitelli MR; Pantarotto M; Torri V; Mangioni C; D'Incalci M Gynecol Oncol; 1997 Apr; 65(1):130-7. PubMed ID: 9103402 [TBL] [Abstract][Full Text] [Related]
14. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes. Bank BB; Kanganis D; Liebes LF; Silber R Cancer Res; 1989 Feb; 49(3):554-9. PubMed ID: 2910477 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin. Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813 [TBL] [Abstract][Full Text] [Related]
17. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes. Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine. Balakrishnan K; Wierda WG; Keating MJ; Gandhi V Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456 [TBL] [Abstract][Full Text] [Related]
19. Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome. Müller MR; Seiler F; Thomale J; Buschfort C; Rajewsky MF; Seeber S Cancer Res; 1994 Aug; 54(16):4524-31. PubMed ID: 8044803 [TBL] [Abstract][Full Text] [Related]
20. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size. Brooks N; McHugh PJ; Lee M; Hartley JA Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]